Cambridge Healthtech Institute’s 3rd Annual

Artificial Intelligence in Clinical Research

Machine Learning and AI to Advance Clinical Operations and Data Management

February 20-21, 2020


Artificial intelligence (AI) and machine learning (ML) have propelled many industries toward a new, highly functional and powerful state. Now they are starting to make their way into the clinical research realm advancing clinical operations, as well as data management. Many pharmaceutical companies and larger CROs are starting projects involving some elements of AI, ML, and robotic process automation in clinical trials. CHI’s 3rd Annual Artificial Intelligence in Clinical Research conference is designed to facilitate the discussion and to accelerate the adoption of these approaches in clinical trials.

Arrive early and attend Part 1 (Wed - Thurs): Clinical Data Strategy and Analytics

Preliminary Agenda

STREAMLINING CLINICAL OPERATIONS WITH THE HELP OF AI TECHNOLOGY

Clinical Pitfalls in Using AI for Decision Support

Sujay Kakarmath, MD, MS, Lead Scientist, Data Science and Artificial Intelligence, Partners Healthcare Pivot Labs

AI to Advance Clinical Trial Design and Execution

Faisal Khan, PhD, Executive Director, Advanced Analytics and Artificial Intelligence, AstraZeneca

Streamlining Clinical Operations with the Help of AI

Balazs Flink, PhD, Head, Clinical Trial Analytics, R&D Business Insights, Bristol-Myers Squibb Co.

AI TO ADVANCE CLINICAL DATA MANAGEMENT

CO-PRESENTATION: Intelligent Machines Take on Clinical Data Management

Prasanna Rao, Head, AI & Data Science, Data Monitoring and Management, Clinical Sciences and Operations, Global Product Development, Pfizer Inc.
Ashley Howard, Manager, Clinical Data Scientist, Pfizer Inc.

Accelerating Clinical Database Set-Up Using Machine Learning & AI

Arun Patnaik, Director, Clinical Data Management, Data Operations, Novartis

AI/ML – Will it Revolutionise Clinical Data Management?

Francis Kendall, Senior Director, Biostatistics & Programming, Cytel

PLENARY KEYNOTES

Tuesday Evening, Wednesday Morning, Wednesday Afternoon Plenary Keynotes Featuring:

SCOPE’s 2020 Participant Engagement Award, in Memory of Jerry Matczak
Patient Perspectives as an Input to Feasibility and Clinical Trial Design
Digital Trends that Are Changing Clinical Research
Health Literacy Throughout Drug Development – Why It Matters to Pharma and to Patients
Implementing an Innovation Methodology to Accelerate Clinical Trial Innovation within Your Organization

For more details on the Plenary Keynotes: www.scopesummit.com/keynotes
For more details on the Participant Engagement Award: www.scopesummit.com/participant-engagement-award

INTERACTIVE BREAKOUT DISCUSSION GROUPS

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing: www.scopesummit.com/breakouts

 

Arrive early and attend Part 1 (Wed - Thurs): Clinical Data Strategy and Analytics




For more details on the conference, please contact:
Marina Fishtinsky, MD
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781.972.5496
Email: mfilshtinsky@healthtech.com

For partnering and sponsorship information, please contact:

Companies A-K
Ilana Quigley
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.5457
Email: iquigley@healthtech.com

Companies L-Z
Patty Rose
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.1349
Email: prose@healthtech.com